Drug-Induced Impulse Control Disorders: A Review

被引:13
作者
Atmaca, Murad [1 ]
机构
[1] Firat Univ, Sch Med, Dept Psychiat, Elazig, Turkey
来源
CURRENT CLINICAL PHARMACOLOGY | 2014年 / 9卷 / 01期
关键词
Impulse control disorders; dopaminergic agents; pathological gambling;
D O I
10.2174/1574884708666131111202954
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The essential characteristic of impulse disorders is the failure to resist an impulse, drive or temptation to perform an act that is harmful to the person or to others. Clearly, impulse control disorders can occur without an induction of any drugs, and they may lead to very problematic situations that affect the adjustment of the patient and need to be treated immediately. However, the subject of the present review is impulsivity induced by a variety of drugs. In this context, the most frequently established agents are dopaminergic agonists that may affect the mesolimbic dopaminergic pathway, such as cocaine and methamphetamine. In Parkinson's disease, the triggering effect of levodopa on pounding has been known since the first description of the condition by Friedman. In this paper, we reviewed the role of a variety of psychopharmacological agents, including dopaminergic ones on the occurrence of impulse control disorders, by searching the PubMed database for relevant articles published in the period between 1980 and 2012 August in detail.
引用
收藏
页码:70 / 74
页数:5
相关论文
共 49 条
[1]  
American Psychiatric Association (APA), 2000, AM PSYCH ASS APA DIA
[2]   Behavioural Adverse Effects of Dopaminergic Treatments in Parkinson's Disease Incidence, Neurobiological Basis, Management and Prevention [J].
Antonini, Angelo ;
Cilia, Roberto .
DRUG SAFETY, 2009, 32 (06) :475-488
[3]   A systematic review of modafinil: Potential clinical uses and mechanisms of action [J].
Ballon, Jacob S. ;
Feifel, David .
JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (04) :554-566
[4]  
Blanco C, 1996, AM J PSYCHIAT, V153, P119
[5]  
Blum K, 1996, AM SCI, V84, P132
[6]   Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinsons patients [J].
Bodi, Nikoletta ;
Keri, Szabolcs ;
Nagy, Helga ;
Moustafa, Ahmed ;
Myers, Catherine E. ;
Daw, Nathaniel ;
Dibo, Gyoergy ;
Takats, Annamaria ;
Bereczki, Daniel ;
Gluck, Mark A. .
BRAIN, 2009, 132 :2385-2395
[7]   Opioid Antagonist Naltrexone for the Treatment of Pathological Gambling in Parkinson Disease [J].
Bosco, Domenico ;
Plastino, Massimiliano ;
Colica, Carmela ;
Bosco, Francesca ;
Arianna, Spano ;
Vecchio, Antonino ;
Galati, Francesco ;
Cristiano, Dario ;
Consoli, Arturo ;
Consoli, Domenico .
CLINICAL NEUROPHARMACOLOGY, 2012, 35 (03) :118-120
[8]   LOW PLATELET MONOAMINE-OXIDASE ACTIVITY IN PATHOLOGICAL GAMBLING [J].
CARRASCO, JL ;
SAIZRUIZ, J ;
HOLLANDER, E ;
CESAR, J ;
LOPEZIBOR, JJ .
ACTA PSYCHIATRICA SCANDINAVICA, 1994, 90 (06) :427-431
[9]   Pyromania Associated with Escitalopram in a Child [J].
Ceylan, Mehmet Fatih ;
Durukan, Ibrahim ;
Turkbay, Tumer ;
Akca, Omer Faruk ;
Kara, Koray .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2011, 21 (04) :381-382
[10]   Functional Abnormalities Underlying Pathological Gambling in Parkinson Disease [J].
Cilia, Roberto ;
Siri, Chiara ;
Marotta, Giorgio ;
Isaias, Ioannis U. ;
De Gaspari, Danilo ;
Canesi, Margherita ;
Pezzoli, Gianni ;
Antonini, Angelo .
ARCHIVES OF NEUROLOGY, 2008, 65 (12) :1604-1611